1887

Abstract

SUMMARY

The persistence of Hepatitis B surface antigen (HBsAg) in 156 patients with histopathologically proven acute viral hepatitis and 27 patients with chronic active hepatitis was assessed and correlated with their clinical and histopathological outcome; 1387 sequential serum samples were tested for HBsAg and its antibody (anti HBs). In the group with acute viral hepatitis, 86% of the patients who recovered, 67% of the patients who deteriorated histopathologically and 67% of the fatal cases carried HBsAg for up to 8 weeks only. While 56% of patients with chronic active hepatitis harboured HBsAg for 13-80 weeks, only 10% of the group with acute viral hepatitis did so. Of patients with chronic active hepatitis 37% deteriorated to cirrhosis and 11% died. Diverse anti-HBs-response patterns are reported and may have clinical significance.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-16-2-227
1983-05-01
2022-05-21
Loading full text...

Full text loading...

/deliver/fulltext/jmm/16/2/medmicro-16-2-227.html?itemId=/content/journal/jmm/10.1099/00222615-16-2-227&mimeType=html&fmt=ahah

References

  1. Almeida J. D., Waterson A. P. 1975; Hepatitis B antigen—an incomplete history. American Journal of Medical Sciences 270:105–114
    [Google Scholar]
  2. Anderson W. A. D., Kissane J. M. 1977; In Pathology. VHth ed., vol 2: Mosby C.V. Saint Louis; MO: pp 1321–1438
    [Google Scholar]
  3. Blumberg B. S. 1975; A short history of Australia antigen. In Drugs and the liver edited by Gerok W., Sickinger K. Schattauer Verlag; Stuttgart: pp 7–23
    [Google Scholar]
  4. Dietrichson O., Nielson J. O. 1975; Hepatitis-B antigen as a prognostic marker in acute and chronic hepatitis. Scandinavian Journal of Clinical Laboratory Investigation 35: Suppl 14393
    [Google Scholar]
  5. Iwarson S., Norkrans G. 1975; Outcome of Hepatitis B infection. Scandinavian Journal of Clinical Laboratory Investigation 35: Suppl 14392
    [Google Scholar]
  6. Melnick J. L., Dreesman G. R., Hollinger F. B. 1976; Approaching the control of viral hepatitis type B. Journal of Infectious Diseases 133:210–229
    [Google Scholar]
  7. Pesendorfer F., Krassnitsky O., Wewalka F. 1970; Immunodiffusion and Immuno-electrophoretic technique. Vox Sanguinis 19:200–204
    [Google Scholar]
  8. Redeker A. G. 1975; Viral hepatitis: Clinical aspects. American Journal of Medical Sciences 270:9–16
    [Google Scholar]
  9. Thygarajan S. P., Subramanian S., Solomon S., Panchanadam M., Madanagopalan N. 1980; Pattern of occurrence of HBeAg and anti HBe among blood donors and patients with liver diseases in Tamilnadu. Indian Journal of Medical Research 71:309–315
    [Google Scholar]
  10. World Health Organization 1970; Viral hepatitis and tests for the Australia (Hepatitis associated) antigen and antibody. Bulletin of the World Health Organization 42:957–992
    [Google Scholar]
  11. World Health Organization 1977; Advances in viral hepatitis, Report of the WHO expert committee on viral hepatitis. World Health Organization Technical Report Series no. 602
    [Google Scholar]
  12. Zuckerman A. J., Scalise G., Mazaheri M. R., Kermastinou J., Howard R., Sorensen K. 1975; Transmission of Hepatitis B to the Rhesus monkey, in International symposium on viral hepatitis, Milan, 1974. Developmental Biology 30:236–239
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-16-2-227
Loading
/content/journal/jmm/10.1099/00222615-16-2-227
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error